These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19782064)

  • 1. Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo.
    Sakai M; Ferraz-de-Paula V; Pinheiro ML; Ribeiro A; Quinteiro-Filho WM; Rone MB; Martinez-Arguelles DB; Dagli ML; Papadopoulos V; Palermo-Neto J
    Eur J Pharmacol; 2010 Jan; 626(2-3):131-8. PubMed ID: 19782064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peripheral-type benzodiazepine receptor ligands on Ehrlich tumor cell proliferation.
    Sakai M; Fonseca ES; Oloris SC; Matsuzaki P; Otake AH; Leite KR; Massoco CO; Dagli ML; Palermo-Neto J
    Eur J Pharmacol; 2006 Nov; 550(1-3):8-14. PubMed ID: 17027961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
    Wolf L; Bauer A; Melchner D; Hallof-Buestrich H; Stoertebecker P; Haen E; Kreutz M; Sarubin N; Milenkovic VM; Wetzel CH; Rupprecht R; Nothdurfter C
    Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands.
    Falchi AM; Battetta B; Sanna F; Piludu M; Sogos V; Serra M; Melis M; Putzolu M; Diaz G
    Neuropharmacology; 2007 Aug; 53(2):318-29. PubMed ID: 17631921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.
    Ostuni MA; Ducroc R; Péranzi G; Tonon MC; Papadopoulos V; Lacapere JJ
    Biol Cell; 2007 Nov; 99(11):639-47. PubMed ID: 17561806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of translocator protein (18 kDa)-ligand binding on neurotransmitter-induced salivary secretion in rat submandibular glands.
    Ostuni MA; Tumilasci OR; Péranzi G; Cardoso EM; Contreras LN; Arregger AL; Papadopoulos V; Lacapere JJ
    Biol Cell; 2008 Jul; 100(7):427-39. PubMed ID: 18269350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
    Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
    Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine.
    Ostuni MA; Péranzi G; Ducroc RA; Fasseu M; Vidic B; Dumont J; Papadopoulos V; Lacapere JJ
    Biol Cell; 2009 Jul; 101(10):573-86. PubMed ID: 19392661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the ligand binding sites in the translocator protein TSPO using the chimeric bacterial-mammalian constructs.
    Graeber E; Korkhov VM
    Protein Expr Purif; 2019 Dec; 164():105456. PubMed ID: 31326501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
    Veenman L; Papadopoulos V; Gavish M
    Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazepam effects on Ehrlich tumor growth and macrophage activity in mice.
    Sakai M; Fonseca ES; Dagli ML; Palermo-Neto J
    Life Sci; 2006 Mar; 78(16):1777-83. PubMed ID: 16257421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 18 kDa translocator protein influences angiogenesis, as well as aggressiveness, adhesion, migration, and proliferation of glioblastoma cells.
    Bode J; Veenman L; Caballero B; Lakomek M; Kugler W; Gavish M
    Pharmacogenet Genomics; 2012 Jul; 22(7):538-50. PubMed ID: 22547081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocator protein 18 kDa is involved in the regulation of reactive gliosis.
    Veiga S; Carrero P; Pernia O; Azcoitia I; Garcia-Segura LM
    Glia; 2007 Nov; 55(14):1426-36. PubMed ID: 17674368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells.
    Zeno S; Zaaroor M; Leschiner S; Veenman L; Gavish M
    Biochemistry; 2009 Jun; 48(21):4652-61. PubMed ID: 19358520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent bimodal effect of specific 18 kDa translocator protein (TSPO) ligands on cell death processes induced by ammonium chloride: potential implications for neuropathological effects due to hyperammonemia.
    Caballero B; Veenman L; Bode J; Leschiner S; Gavish M
    CNS Neurol Disord Drug Targets; 2014; 13(4):574-92. PubMed ID: 24168369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.
    Lee YS; Siméon FG; Briard E; Pike VW
    ACS Chem Neurosci; 2012 Apr; 3(4):325-35. PubMed ID: 22860199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat.
    Yanamoto K; Yamasaki T; Kumata K; Yui J; Odawara C; Kawamura K; Hatori A; Inoue O; Yamaguchi M; Suzuki K; Zhang MR
    Synapse; 2009 Nov; 63(11):961-71. PubMed ID: 19593823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production.
    Danovich L; Veenman L; Leschiner S; Lahav M; Shuster V; Weizman A; Gavish M
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):24-33. PubMed ID: 17561380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.